MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, MRKR has $19,070,997 in assets. $2,274,183 in debts. $16,068,048 in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
838.59%
Quick Ratio
838.59%
Cash Ratio
706.54%
Debt to Asset Ratio
11.92%
Unit: Dollar
Assets Breakdown
    • Cash and cash equivalents
    • Restricted cash
    • Prepaid expenses and deposits
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Accounts payable and accrued lia...
    • Others

Balance Sheets
2025-12-31
Cash and cash equivalents
16,068,048
Restricted cash
974,799
Prepaid expenses and deposits
658,750
Other receivables
1,369,400
Total current assets
19,070,997
Total assets
19,070,997
Accounts payable and accrued liabilities
1,299,384
Deferred revenue
974,799
Total current liabilities
2,274,183
Total liabilities
2,274,183
Common stock, 0.001 par value, 30 million shares authorized, 16.7 million and 10.7 million shares issued and outstanding as of december 31, 2025 and 2024, respectively (see note 7)
16,672
Additional paid-in capital
475,960,940
Accumulated deficit
-459,180,798
Total stockholders' equity
16,796,814
Total liabilities and stockholders' equity
19,070,997
Unit: Dollar.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$16,068,048 Other receivables$1,369,400 Restricted cash$974,799 Prepaid expenses anddeposits$658,750 Total current assets$19,070,997 Total assets$19,070,997 Total liabilities andstockholders' equity$19,070,997 Total stockholders'equity$16,796,814 Total liabilities$2,274,183 Accumulated deficit-$459,180,798 Additional paid-in capital$475,960,940 Total currentliabilities$2,274,183 Common stock, 0.001 parvalue, 30 million...$16,672 Accounts payable andaccrued liabilities$1,299,384 Deferred revenue$974,799

Marker Therapeutics, Inc. (MRKR)

Marker Therapeutics, Inc. (MRKR)